Join our community of smart investors

Bioventix assured as industry demand wavers

The biotech firm has awarded another special dividend
Bioventix assured as industry demand wavers
  • Global demand levels still hampered by pandemic focus
  • Current dividend policy to be maintained

Though Bioventix (BVXP) registered another steady increase in sales of its sheep monoclonal antibodies (SMAs), profitability was constricted due to adverse foreign exchange translations.

To continue reading...
Join our Community of Smart Investors
  • Independent full-length company analysis
  • Actionable investment ideas and recommendations
  • Expert investment tools and data
  • Stock screens from Algy Hall
Have an account? Sign in